Antimicrobial genes play an important role as a primary defense mechanism in all multicellular organisms. We chose Bacillus subtilis as a target pathogen indicator and transferred the Aegilops tauschii Cosson cDNA library into B. subtilis cells. Expression of the candidate antimicrobial gene can inhibit B. subtilis cell growth. Using this strategy, we screened six genes that have an internal effect on the indicator bacteria. Then, the secreted proteins were extracted and tested; two genes, AtR100 and AtR472, were found to have strong external antimicrobial activities with broad-spectrum resistance against Xanthomonas oryzae pv. oryzicola, Clavibacter fangii, and Botrytis cinerea. Additionally, thermal stability tests indicated that the antimicrobial activities of both proteins were thermostable. Furthermore, these two proteins exhibited no significant hemolytic activities. To test the feasibility of application at the industrial level, liquid fermentation and spray drying of these two proteins were conducted. Powder dilutions were shown to have significant inhibitory effects on B. cinerea. Fluorescence microscopy and flow cytometry results showed that the purified protein impaired and targeted the cell membranes. This study revealed that these two antimicrobial peptides could potentially be used for replacing antibiotics, which would provide the chance to reduce the emergence of drug resistance. Antibiotics have been widely used worldwide in recent decades to control many pathogens. Due to the excessive use of antibiotics, many bacteria have already developed antibiotic resistance mechanisms 1,2. Meanwhile, pathogen resistance has become a serious global threat, especially in intensive care units, where resistance often occurs 3,4. The increasing number of multi-drug-resistant pathogens has led to a growing demand for new antibiotics; however, even if new antibiotics are identified, resistance cannot be avoided because of antibiotic overuse, which is the primary cause of antibiotic resistance 5,6. With the increasing use of antibiotics, there is an urgent need to produce something with a negative impact against resistance mechanisms; thus, new therapeutic agents to replace antibiotics must be found. Antimicrobial peptides (AMPs) are potential substitutes for antibiotics because of their broad-spectrum resistance and rare resistant variants 7. These peptides have broad activity against a variety of bacteria, fungi, viruses, parasites, and cancer cells; furthermore, almost all organisms have a variety of broad-spectrum antimicrobial peptides 8. An antimicrobial peptide is an amphiphilic, cationic, and small protein in organisms as well as an important component of the innate immune system 9. The natural immunity of many organisms relies on the invasive power of antimicrobial peptides against different microbes 10. Since some antimicrobial peptides are biologically safe and are not susceptible to drug resistance, more and more of these have been discovered and excavated 11-14 , and the discovery and application of a...